NM_015458.4(MTMR9):c.328C>G (p.Pro110Ala) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 26, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004128023.1

Allele description [Variation Report for NM_015458.4(MTMR9):c.328C>G (p.Pro110Ala)]

NM_015458.4(MTMR9):c.328C>G (p.Pro110Ala)

Gene:

MTMR9:myotubularin related protein 9 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

8p23.1

Genomic location:

Preferred name:

NM_015458.4(MTMR9):c.328C>G (p.Pro110Ala)

HGVS:

NC_000008.11:g.11300059C>G
NM_015458.4:c.328C>GMANE SELECT
NP_056273.2:p.Pro110Ala
NC_000008.10:g.11157568C>G
NM_015458.3:c.328C>G

Protein change:

P110A

Molecular consequence:

NM_015458.4:c.328C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

TLD domain containing protein [Entamoeba histolytica HM-1:IMSS-B]
TLD domain containing protein [Entamoeba histolytica HM-1:IMSS-B]
gi|459660932|gb|EMH76197.1||gnl|WGS |cds.EHI8A_125640A

Protein
Chain B, Protein kinase, putative
Chain B, Protein kinase, putative
gi|723586762|pdb|4NL0|B

Protein
Taxonomy Links for Nucleotide (Select 2090364520) (1)
Taxonomy
PopSet Links for Taxonomy (Select 368895) (2)
PopSet
PREDICTED: Rattus norvegicus Rho GTPase activating protein 17 (Arhgap17), transc...
PREDICTED: Rattus norvegicus Rho GTPase activating protein 17 (Arhgap17), transcript variant X3, misc_RNA
gi|1046844084|ref|XR_350690.3|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003600173	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Jan 26, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003600173

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Jan 26, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003600173.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.328C>G (p.P110A) alteration is located in exon 3 (coding exon 3) of the MTMR9 gene. This alteration results from a C to G substitution at nucleotide position 328, causing the proline (P) at amino acid position 110 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 10, 2024

ClinVar

Relating variation to medicine